What's breaking now, across thousands of outlets.
In an interview with BioPharma Dive, Compass executives said that, should the FDA approve their treatment, they hope to capitalize on a strategy pioneered by J&J in selling the ketamine spray Spravato.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
A scientific symposium organized by the Regenerative Medicine Society explored the latest research and applications of regenerative medicine in women’s reproductive health.
New facility to provide comprehensive maternal, child and reproductive healthcare services.
Chronic inflammation tied to stress, lifestyle, mental health, and socioeconomic conditions may silently change the heart for years before any symptoms appear.
